As CEO of Cost Plus Drug Co., Mark Cuban is telling other CEOs: "If the big 3 PBMs, which also own the insurance companies, lose 5 of the top 15 non-PBM Fortune 50 companies, their business practices are going to change."

Since the IRS announced the moratorium on new ERC claims in September, the agency has now released new guidelines for small employers that wish to cancel their claim if they have doubts about its legitimacy.

Obesity's complicated, as the disease is associated with multiple chronic conditions, but a new generation of weight loss drugs has shifted the treatment landscape, creating both a challenge and an opportunity for employers.

The hiring spree is in anticipation of more lawsuits, on the heels of one filed in Louisiana last month by six vaccine-injured plaintiffs against the federal government, which aims to overturn the legal immunity that Big Pharma now has.

A class-action lawsuit filed on Tuesday alleges UnitedHealthcare's algorithm overrode physician recommendations, wrongfully denying coverage under Medicare Advantage policies for stays in extended-care facilities.

Artificial intelligence could reduce clinicians' administrative work and accelerate drug innovation, but the new technology needs oversight, said lawmakers, who met last week to discuss benefits as well as possible threats of AI.

More than one-third of companies are disclosing individual pay ranges to employees, and an even larger number (46%) are planning or considering doing so in the future.

Spending on primary care fell from an average of 6.2% in 2013 to 4.6% in 2020.